The proposed rule creates three tiers of providers who could prescribe controlled drugs. The first tier comprises clinicians wanting to prescribe Schedule III-V level drugs; the second would apply ...

The DEA is planning to reclassify marijuana from a Schedule I to a Schedule III controlled substance. The shift, which would still require ultimate approval from the White House, could broaden ...

The Drug Enforcement Administration ... for providers offering controlled substance prescriptions over telehealth: one allows clinicians to prescribe Schedule III to V controlled substances ...

Physicians would have to register with the Drug Enforcement Administration ... Under the rule, providers who prescribe Schedule III-V controlled substances would need to apply for a special ...

the Drug Enforcement Administration (DEA) issued a temporary scheduling order (TSO) for fentanyl as a Schedule I drug under the Controlled Substances Act (CSA), but the TSO is set to expire in March.

DEA also proposed two additional requirements for clinicians issuing a prescription for a Schedule II controlled substance, requiring that: In the NPRM, DEA states that it intends to finalize at ...

In 2018, the Drug Enforcement Administration (DEA) issued a temporary scheduling order (TSO) for fentanyl as a Schedule I drug under the Controlled Substances Act (CSA), but the TSO is set to expire ...